Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 306 of 6351
-
Could a simple pill combo prevent preterm birth? new trial aims to find out
Prevention Not yet recruitingThis protocol describes a seamless Phase II/III, randomized, double-blind clinical trial evaluating the efficacy and safety of daily low-dose aspirin (81 mg) plus lansoprazole (30 mg) in pregnant individuals at high risk for preterm birth when compared to existing standard of car…
Phase 2/3 • Sponsor: Stanford University • Aim: Prevention
Last updated Jun 27, 2026 08:10 UTC
-
Draining fluid early after brain bleed may boost recovery
Disease control Not yet recruitingThis is a multicenter, prospective, randomized, open-label, blinded-endpoint (PROBE) trial in Chinese patients with intraventricular hemorrhage (IVH), comparing early lumbar drainage added to standard care with standard care alone. The primary objective is to evaluate whether, in…
Sponsor: Second Affiliated Hospital of Nanchang University • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Freezing breast tumors: a new hope for metastatic cancer control?
Disease control Not yet recruitingMetastatic breast cancer remains an incurable disease for most patients. While surgical treatment of the primary breast tumor is commonly performed in localized breast cancer, its role in metastatic breast cancer remains controversial due to the lack of demonstrated survival bene…
Sponsor: Hospices Civils de Lyon • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New targeted pill holds promise for rare salivary gland cancer that spreads
Disease control Not yet recruitingAdenoid cystic carcinomas are rare cancers of the salivary glands. These cancers are treated with curative surgery, often followed by radiation therapy. Despite this aggressive treatment, approximately 50% of patients will develop a recurrence or metastatic disease (spread of the…
Phase 2 • Sponsor: UNICANCER • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Blood test could tell doctors when to stop prostate cancer treatment early
Disease control Recruiting nowThis clinical trial studies whether measuring circulating tumor deoxyribonucleic acid (ctDNA) tumor fraction (TF) can be used to help guide the early stopping (discontinuation) of lutetium Lu 177 vipivotide tetraxetan (177Lu-PSMA-617) in patients with castration-resistant prostat…
Phase 2 • Sponsor: University of Washington • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
AI chat could be a secret weapon against dementia in lonely seniors
Disease control Not yet recruitingThis randomized controlled trial examines the mechanisms of conversational AI-based interventions for early dementia prevention in socially isolated older adults.
Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC
-
MRI scans may reveal hidden clues to myeloma relapse risk
Knowledge-focused Not yet recruitingThis is a multicenter, observational, retrospective-prospective study designed to validate the predictive role of advanced imaging in patients with newly diagnosed multiple myeloma (NDMM). The main purpose of this study is to estimate the prevalence of radiological response categ…
Sponsor: Fondazione EMN Italy Onlus • Aim: Knowledge-focused
Last updated Sep 10, 2026 02:00 UTC
-
AI therapy coach aims to ease distress in seriously ill seniors
Symptom relief Not yet recruitingLay / General Audience Summary Many older adults living with serious illnesses experience high levels of emotional distress, including anxiety, sadness, fear, and feeling overwhelmed. These feelings often worsen as illness progresses and can make physical symptoms harder to manag…
Phase 1 • Sponsor: Rutgers, The State University of New Jersey • Aim: Symptom relief
Last updated Aug 07, 2026 00:00 UTC
-
Can a specialized hand exercise protocol restore grip and ease pain in rheumatoid arthritis?
Symptom relief Not yet recruitingRheumatoid arthritis (RA) frequently affects the hand and wrist, resulting in pain, reduced joint stability, impaired proprioception, muscle weakness, and limitations in daily activities. Although conventional rehabilitation primarily focuses on range of motion and strengthening …
Sponsor: Istanbul University - Cerrahpasa • Aim: Symptom relief
Last updated Aug 16, 2026 00:00 UTC
-
Can a lifestyle coach lower your risk of stroke and dementia?
Prevention Not yet recruitingVascular risk factors drive stroke, heart disease, and dementia, but translating lifestyle guidelines into routine clinical care remains challenging. To address this, we developed BASIC-S (Blood Pressure, Activity, Sleep, Interaction, Consumption, and Support), a framework target…
Sponsor: Andrew Appleton • Aim: Prevention
Last updated Aug 27, 2026 00:00 UTC
-
Can donor immune cells tame stem cell transplant risks?
Disease control Not yet recruitingThe goal of this clinical trial is to learn if agenT-797 is safe to use on people undergoing allogenic hematological stem cell transplantation (SCT). The main questions it aims to answer are: * Is agenT-797 safe to use? * What medical problems do participants have when taking ag…
Phase 1 • Sponsor: University of Wisconsin, Madison • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Food as medicine: could cooking classes slow kidney disease?
Disease control Not yet recruitingHealthy eating plays an important role in kidney and heart health, and programs that use food as medicine can help improve diet and overall health, but the best ways to support healthy eating in community settings are not well understood. The purpose of this study is to compare t…
Sponsor: University of Texas Southwestern Medical Center • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
Could continuing a common heart drug before surgery save lives?
Disease control Not yet recruitingSGLT-2 inhibitors are recommended treatments for managing heart failure patients. In cases of surgery, it is recommended to stop the treatment 3 days before surgery due to the risk of postoperative euglycemic diabetic ketoacidosis. However, several data suggest that it may be ben…
Phase 4 • Sponsor: University Hospital, Toulouse • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
Can a vacuum device safely suck out dangerous heart clots? a global registry investigates
Knowledge-focused Not yet recruitingAs a structured, multinational retrospective registry the AVATAR Registry addresses the following scientific aspects through systematic data collection, centralized quality control, and robust statistical analysis in patients that were treated with the AngioVac Aspiration System:…
Sponsor: Charite University, Berlin, Germany • Aim: Knowledge-focused
Last updated Aug 19, 2026 00:00 UTC
-
Smartwatch-Guided prehab aims to boost pancreatic surgery recovery
Disease control Not yet recruitingThe goal of this clinical trial is to evaluate whether a wearable-enabled prehabilitation and rehabilitation pathway can improve recovery and post-operative outcomes in adults undergoing surgery for pancreatic cancer or related pancreatic/periampullary conditions. The main quest…
Sponsor: Manchester University NHS Foundation Trust • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
Warming hands may sharpen oxygen readings in ICU patients
Disease control Not yet recruitingPulse oximeters are widely used in intensive care to continuously estimate the oxygen level in the blood. However, pulse oximeter measurements may be less accurate when blood flow to the fingers is poor, which is common in critically ill patients. This study will investigate whe…
Sponsor: Vastra Gotaland Region • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
Can a skin cream calm the immune attack after stem cell transplants?
Disease control Not yet recruitingThe purpose of this study is to see if ruxolitinib, a Janus Kinase (JAK) 1/2 inhibitor, is safe for people who have acute skin graft versus host disease (GVHD) following allogenic hematopoietic stem cell transplantation (HSCT).
Phase 1 • Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Which pacing target keeps the heart stronger? a trial aims to find out
Disease control Not yet recruitingThis is a prospective, multicenter, randomized controlled trial designed to determine whether direct capture of the left ventricular conduction system must be achieved as the procedural endpoint of left bundle branch area pacing (LBBAP), or whether left ventricular septal capture…
Sponsor: Yonsei University • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Can a blood test catch lupus flares earlier?
Diagnosis Not yet recruitingSystemic lupus erythematosus (SLE) is a chronic autoimmune disease characterized by immune system dysregulation and inflammation affecting multiple organs. A key mechanism in its development involves the excessive formation and impaired clearance of neutrophil extracellular traps…
Sponsor: Assiut University • Aim: Diagnosis
Last updated Sep 10, 2026 00:00 UTC
-
Light and electrical pulses: a new combo to rewire the brain after stroke?
Disease control Not yet recruitingThis study will evaluate the effects of functional electrical stimulation (FES) cycling, cognitive task training, and non-invasive photobiomodulation on cognitive and upper-limb motor performance in adults after stroke. The study includes three stages to identify favorable FES cy…
Sponsor: Chang Gung Memorial Hospital • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC